PCM
BHC icon

Portolan Capital Management’s Bausch Health BHC Stock Holding History

Portolan Capital Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-8,917
Closed -$768K – 136
2013
Q2 		$768K Buy
+8,917
New +$703K 0.22% 104

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Portolan Capital Management's BHC Position: Q3 2013 in Review

Portolan Capital Management sold out of Bausch Health (BHC) in Q3 2013, closing a stake of 8,917 shares — an estimated $768K sold.

Portolan Capital Management first reported a position in BHC in Q2 2013 and held it in 1 quarter. The position peaked at $768K in Q2 2013. 368 funds tracked by Wall St. Rank hold BHC as of Q3 2013.

  • Portolan Capital Management reported no remaining Bausch Health position as of Q3 2013 after selling out during the quarter.
  • Portolan Capital Management sold 8,917 Bausch Health shares in Q3 2013, an estimated $768K.
  • Portolan Capital Management first reported a position in Bausch Health in Q2 2013 and held it in 1 quarter.
  • Portolan Capital Management's Bausch Health position peaked at $768K in Q2 2013.
  • 368 funds tracked by Wall St. Rank held Bausch Health as of Q3 2013.

Based on Portolan Capital Management's 13F filing for Q3 2013, filed 8 Nov 2013.